Blood Cancer Journal (May 2025)
Correction: Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
- Warren Fiskus,
- Christopher P. Mill,
- Christine Birdwell,
- John A. Davis,
- Kaberi Das,
- Steffen Boettcher,
- Tapan M. Kadia,
- Courtney D. DiNardo,
- Koichi Takahashi,
- Sanam Loghavi,
- Michael J. Soth,
- Tim Heffernan,
- Gerard M. McGeehan,
- Xinjia Ruan,
- Xiaoping Su,
- Christopher R. Vakoc,
- Naval Daver,
- Kapil N. Bhalla
Affiliations
- Warren Fiskus
- The University of Texas MD Anderson Cancer Center
- Christopher P. Mill
- The University of Texas MD Anderson Cancer Center
- Christine Birdwell
- The University of Texas MD Anderson Cancer Center
- John A. Davis
- The University of Texas MD Anderson Cancer Center
- Kaberi Das
- The University of Texas MD Anderson Cancer Center
- Steffen Boettcher
- University of Zurich and University Hospital Zurich
- Tapan M. Kadia
- The University of Texas MD Anderson Cancer Center
- Courtney D. DiNardo
- The University of Texas MD Anderson Cancer Center
- Koichi Takahashi
- The University of Texas MD Anderson Cancer Center
- Sanam Loghavi
- The University of Texas MD Anderson Cancer Center
- Michael J. Soth
- The University of Texas MD Anderson Cancer Center
- Tim Heffernan
- The University of Texas MD Anderson Cancer Center
- Gerard M. McGeehan
- Syndax Pharmaceuticals
- Xinjia Ruan
- The University of Texas MD Anderson Cancer Center
- Xiaoping Su
- The University of Texas MD Anderson Cancer Center
- Christopher R. Vakoc
- Cold Spring Harbor Laboratory
- Naval Daver
- The University of Texas MD Anderson Cancer Center
- Kapil N. Bhalla
- The University of Texas MD Anderson Cancer Center
- DOI
- https://doi.org/10.1038/s41408-025-01306-9
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 2
Abstract
No abstracts available.
